Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aviv Venture Capital, founded in 2001 and headquartered in Israel, specializes in high-tech investments. The firm targets companies that develop breakthrough technologies offering unique solutions to large markets. Aviv emphasizes strong intellectual property positions, which enable portfolio companies to achieve competitive advantages in time-to-market. The firm has built a reputation for identifying and supporting innovative startups across various sectors.
Currently, Aviv manages a portfolio of 37 companies, focusing on sectors such as AI, healthcare, fintech, and energy. The firm operates primarily in North America, Europe, and Asia, leveraging its geographical reach to tap into diverse markets. Aviv's team consists of experienced professionals who provide strategic guidance and support to portfolio companies, helping them navigate market challenges and accelerate growth.
Over the years, Aviv has achieved notable milestones, including successful exits such as OrCam and Valens Semiconductors. The firm continues to seek out high-potential startups that align with its investment thesis, aiming to foster innovation and drive significant impacts in their respective industries.
Aviv Venture Capital invests primarily in high-tech sectors, including AI, healthcare, biotech, fintech, energy, climate, consumer, commerce, industrial, and defense. The firm targets companies at the seed, Series A, and Series B stages, focusing on those with unique product offerings and a strong intellectual property foundation. Aviv seeks to partner with firms that demonstrate the potential for significant market impact and possess defensible intellectual property, which is crucial for achieving a competitive time-to-market advantage.
The firm emphasizes its investment thesis of identifying 'one of a kind' solutions that address large market needs. Aviv's geographic focus spans North America, Europe, and Asia, allowing it to engage with a diverse range of innovative startups. The firm prefers to invest in revenue-stage companies rather than pre-revenue seed-stage startups, reflecting its strategy to back firms that are already demonstrating traction in their respective markets.
Aviv Venture Capital's portfolio includes a diverse range of companies that exemplify its focus on high-tech innovation. Notable portfolio companies include:
These companies illustrate Aviv's commitment to investing in firms with strong intellectual property and innovative solutions that can disrupt traditional markets. The firm has a track record of successful exits, including acquisitions and IPOs, demonstrating its ability to identify and nurture high-potential startups.
Dr. Amir Guttman - Founder & Managing Partner. Dr. Guttman has over six years of senior management experience at Discount Investments Corp (DIC) and teaches Financial Statements Analysis at the Leon Recanati Graduate School of Business Administration, Tel Aviv University MBA program.
Yoav Chelouche - Managing Partner. Chelouche plays a key role in guiding Aviv's investment strategy and portfolio management.
Gideon Ben-Zvi - Former Venture Partner, currently CEO of Valens Semiconductors. Ben-Zvi is a serial entrepreneur with a track record of founding and co-founding six companies.
Sophie Caspi - Chief Financial Officer. Caspi has a background as a Controller at Walden Israel VC and senior auditor at KPMG Somekh Chaikin. She holds a CPA and an MBA from Tel Aviv University.
To pitch Aviv Venture Capital, founders should visit their website at avivvc.com. It is essential to include a comprehensive pitch deck that outlines the technology, market opportunity, and intellectual property. The firm prefers direct submissions through their website and may take time to respond, reflecting their thorough evaluation process.
In recent activity, Aviv Venture Capital led a $15 million Series B round in AposHealth, showcasing their continued investment in high-tech therapeutic devices. This round included participation from Pitango and other investors.
Aviv has also seen notable exits, including the IPO of Valens Semiconductors and the acquisition of BriefCam and ComQi, highlighting the firm's successful track record in identifying high-potential startups.
As of 2024, there have been no documented new investments, suggesting that Aviv may be in a portfolio management phase rather than actively deploying new capital.
What are Aviv Venture Capital's investment criteria?
Aviv focuses on high-tech companies with unique solutions and strong intellectual property. They invest in sectors such as AI, healthcare, fintech, and energy, primarily at the seed, Series A, and Series B stages.
How can I pitch to Aviv Venture Capital?
Founders can submit their pitches through the firm's website at avivvc.com. It is recommended to include a clear overview of the technology, market opportunity, and intellectual property position in the pitch deck.
What makes Aviv Venture Capital different from other investors?
Aviv emphasizes investments in companies with defensible intellectual property and breakthrough technologies. Their focus on high-tech sectors and strong market potential sets them apart from other venture capital firms.
What is Aviv's geographic focus?
The firm primarily invests in North America, Europe, and Asia, allowing them to tap into a diverse range of innovative startups across different markets.
What is Aviv's post-investment involvement like?
Aviv provides strategic guidance and support to its portfolio companies, leveraging its expertise in high-tech sectors to help them navigate market challenges and accelerate growth trajectories.
What is the typical check size for Aviv's investments?
While specific check sizes are not disclosed, Aviv typically invests in seed, Series A, and Series B rounds, indicating a focus on early to growth-stage funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.